Strides Arcolab unit's Milan-based factory gets FDA OK

09/19/2013 | BioSpectrum Asia

The FDA has approved the drug facility of Strides Arcolab's Italian unit Beltapharm in Milan, allowing the company to enter the U.S. semisolid market. The facility will produce creams, ointments, semisolids and liquids, the drugmaker said in a statement. The facility is already cleared in Australia and the European Union.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA